(Q35541773)
Statements
Epratuzumab: targeting B-cell malignancies through CD22 (English)
Morton Coleman
Michelle Ashe
David M. Goldenberg
Abby B. Siegel
Jamie C. Ketas
Jennifer M. Fiore
1 September 2003
scientific article published on September 1, 2003